Asia-Pacific Life Sciences Centre of Excellence
The rapid evolution of the life sciences industry has been accompanied by fierce competition on a global scale. Exciting medical and scientific innovations offer the promise of better health for patients around the world. At the same time, enormous challenges — including increased pricing pressure, the changing role of consumers, increased regulation and disruption from nontraditional players — make it critical for industry leaders to stay on top of the latest trends and issues.
The Asia-Pacific (APAC) Life Sciences Centre of Excellence is an important part of our broader Healthcare Insights Center and is dedicated to advancing insights and cutting-edge thinking on topics of greatest relevance to life sciences leaders in the APAC region. The Centre is supported by the Singapore Economic Development Board, and leverages L.E.K.’s deep industry knowledge and proprietary tools, as well as Singapore’s strong research ecosystem, to produce materials on a broad range of life sciences and healthcare topics. These range from the future of drug discovery and development to healthcare transformation and digitization.
Visitors to the Centre will find both useful insights and practical knowledge, including best practices from other markets around the world. It is our hope that access to this information will help life sciences companies in APAC become more efficient and effective in addressing their current and future challenges.
Finally, the diversity and complexity of the APAC life sciences market presents a number of hurdles for companies looking to do business the region. The Life Sciences Centre of Excellence provides a compass to help them navigate with greater success. Fabio La Mola, Partner at L.E.K. Consulting, is Executive Director of the APAC Life Sciences Centre of Excellence. He also serves as an advisor for biotech to the Singapore National Research Foundation (NRF) Central Gap Fund.
L.E.K.'s Healthcare Insights Center
Understanding and dissecting the dynamics of the quickly evolving healthcare ecosystem is the central focus of L.E.K.’s HealthCare Insights Center. Our global team of subject matter experts bring novel insights to the most difficult and pressing questions facing healthcare companies today. With access to this information, industry leaders will be well-positioned to not only navigate today’s challenges, but anticipate those on the horizon.
Heading East: Biopharma International Expansion to China and Asia
This Special Report highlights the potential opportunities, entry approaches and local partner selection, and also include recommendations on market acceleration and internationalization.
How Analytics Can Reshape Pharma’s Portfolio Strategy
As factors such as urbanization, population aging, market access and economic growth drive more and more patients to the healthcare system, pharmaceutical companies have the opportunity to launch branded copies or generics across multiple countries and thus increase the size of their portfolios.